Montu J. Patel, MD, presented “MRI First: The Role of MRI in Biopsy Naïve Patients” during the 5th Annual Oklahoma Prostate & Urologic Cancers Symposium on September 13th, 2019 in Oklahoma City, Oklahoma.

How to cite: Patel, Montu J. “MRI First: The Role of MRI in Biopsy Naïve Patients” September 13th, 2019. Accessed Aug 2021.​/

MRI First: The Role of MRI in Biopsy Naïve Patients – Summary:

Monju J. Patel, MD, discusses how variation in mpMRI image quality and radiologist interpretation and experience, as well as technicalities of the PIRADS-2 scoring system, can significantly impact radiologists’ ability to detect lesions suspicious for prostate cancer. He goes on to present several case studies on how to utilize mpMRI’s strong specificity to evaluate extraprostatic extension and anterior transition zone tumors, and how to use mpMRI to evaluate the entire pelvis for possible metastatic disease. Finally, Dr. Patel considers the detection pitfalls of mpMRI, such as differentiating benign anatomy versus a malignancy, abnormalities that exist in the central zone, and how to identify diffuse, infiltrative carcinoma. 

About The 5th Annual Prostate & Urologic Cancer Symposium:

The Prostate & Urologic Cancers Symposium is held through the University of Oklahoma and the Stephenson Cancer Center to provide new insights in the treatment of prostate and urologic cancers. This single-day program consists of lectures and case discussions highlighting a multidisciplinary approach to urologic cancer care and integration of new technology in the evaluation and treatment of patients with prostate and/or urologic cancers. Dr. Patel presented this lecture during the 5th iteration of this summit in 2019. Other presentations from this symposium include:

Expanding the Role of Surgical Management of High-Risk Prostate Cancer
M0 CRPC: Treatment Options and Emerging Concepts